Promoter sequences from WSSV immediate early genes and their uses in recombinant DNA techniques

a technology of promoter sequences and early genes, which is applied in the field of isolated nucleotide sequences, can solve the problems of difficult recovery of proteins, inability to bind to peptides, and inability to bind to proteins,

US20060154369A1Inactive Publication Date: 2006-07-13NAT TAIWAN UNIV
12 Cites 8 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
Publication Date
2006-07-13
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

Disclosed herein are isolated promoter-regulatory regions from a newly identified WSSV immediate early (IE) gene, ie1 (immediate early gene #1), which exhibit promoter activity to drive the transcription of a target gene in non-native host cells. The isolated promoter-regulatory regions can be used in the construction of a variety of recombinant expression vectors for transforming a broad spectrum of host cells.
Need to check novelty before this filing date? Find Prior Art

Description

BACKGROUND OF THE INVENTION

[0001] 1. Field of the Invention

[0002] This invention relates to isolated nucleotide sequences which are derived from a newly identified immediate early gene of white spot syndrome virus (WSSV) and which have promoter activity to drive the transcription of a target gene in a non-native host cell, thus having great potential for use in the field of biotechnology.

[0003] 2. Description of the Related Art

[0004] The production of recombinant polypeptides / proteins is a very important genetic engineering technique in the field of biotechnology. The basic principle involves the cloning of a target gene capable of expressing a desired gene product (e.g., ribozymes and RNA transcripts, industrial and agricultural enzymes, therapeutic proteins, interferons, interleukins, hormones, growth hormones, antigenic polypeptides, antibodies and the like) into a suitable vector, and the subsequent transfer of the resultant recombinant vector into a competent host cell. The...

Examples

examples

I. Materials and Methods

Viral Gene Microarray—Chip Preparation

[0110] The Penaeus monodon WSSV 1994 Taiwan isolate (WSSV T-1), the genome of which was deposited in the NCBI database under accession no. AF440570, was used in all the experiments described below. This WSSV T-1 isolate was deposited in the China Center for Type Culture Collection (CCTCC, Wuhan University, Luo Jia Shan, Wuhan, Hubei, 430072, People's Republic of China) under the Budapest Treaty on Jan. 11, 1996, and was given accession number CCTCC-V96001 (see U.S. Pat. No. 5,824,535 and U.S. Pat. No. 6,190,862 issued to Guang-Hsiung Kou et al.).

[0111] WSSV viral gene microarrays (chips) were designed based on the genome of the WSSV T-1 isolate. Briefly, each chip contains 532 predicted WSSV ORFs and a partial sequence of P. monodon β-actin gene. After conducting polymerase chain reaction (PCR) using specific primers derived from these 532 ORFs, PCR products with amplicon sizes of 200 to 600 bp were spotted on precoa...